Abstract
Acetaminophen can decrease mean plasma lamotrigine AUC values by 20 % and mean elimination half-life values by 15 % and enhances the urinary elimination of lamotrigine via an unknown mechanism [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Depot M, Powell JR, Messenheimer JA, Cloutier G, Dalton MJ. Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin Pharmacol Ther. 1990;48:346–55.
Haan GJD, Edelbroek P, Bartels C. Changes in lamotrigine pharmacokinetics induced by antitubercular drugs. Epilepsia. 2010;51(Supp. 4):26.
Ebert U, Thong NQ, Oertel R, Kirch W. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of Âlamotrigine in healthy volunteers. Eur J Clin Pharmacol. 2000;56:299–304.
Ulivelli M, Rubegni P, Nuti D, Bartalini S, Giannini S, Rossi S. Clinical evidence of fluconazole-induced carbamazepine toxicity. J Neurol. 2004;251:622–3.
Burger DM, Huisman A, van Ewijk N, Neisingh H, van Uden P, Rongen GA, Koopmans P, Bertz RJ. The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe. Clin Pharmacol Ther. 2008;84:698–703.
Van der Lee MJ, Dawood L, ter Hofstede HJM, de Graaff-Teulen MJA, van Ewijk-Beneken-Kolmer EWJ, Caliskan-Yassen N, Koopmans PP, Burger DM. Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy volunteers. Clin Pharmacol Ther. 2006;80:159–68.
van Luin M, Colbers A, Verwey-van Wissen CPWGM, van Ewijk-Beneken-Kolmer EWJ, van der Kolk M, Hoitsam A, Gomesda Silva H, Gomes da Silva H, Burger DM. The effect of raltegravir on the glucuronidation of lamotrigine. J Clin Pharmacol. 2009;49:1220–7.
Normann C, Hummel B, Scharer LO, Horn M, Grunze H, Walden J. Lamotrigine as adjunctive to paroxetine in acute depression: a Âplacebo-controlled, double-blind study. J Clin Psychiatry. 2002;63:337–44.
Kaufman KR, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure. 1998;7:163–5.
Schieber FC, Boulton DW, Balch AH, Croop R, Mallikaarjun S, Benson J, Carlson BX. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder. Hum Psychopharmacol. 2009;24:145–52.
Reimers A, Skogvoll E, Sund JK, Spiget O. Drug interaction between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. J Clin Psychopharmacol. 2005;25:342–8.
Sidhu J, Job S, Bullman J, Francis E, Abbott R, Asher J, Theis JGW. Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects. Br J Clin Pharmacol. 2006;61:420–6.
Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61:570–1.
Odishaw J, Chen C. Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. Pharmacotherapy. 2000;20:1448–14453.
Bigham S, McGuigan C, MacDonald BK. Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat. Epilepsia. 2006;47:2207.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Patsalos, P.N. (2013). Lamotrigine. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_37
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2434-4_37
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2433-7
Online ISBN: 978-1-4471-2434-4
eBook Packages: MedicineMedicine (R0)